Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.9K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.9K
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

189
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
189
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

278
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
278
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

236
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
236
Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

257
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
257
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

215
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
215

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methodologies for generating and evaluating clinical and performance evidence for high-risk and innovative medical devices and <i>in vitro</i> diagnostics: a scoping review.

Frontiers in medical technology·2026
Same author

Methodologies for mapping existent common specification, standards, and overlapping regulation for medical devices: a scoping review.

Expert review of medical devices·2026
Same author

Discovery of pyrimidine-based small activators of insulin degrading enzyme.

European journal of medicinal chemistry·2026
Same author

Maternal Thyroid Disorders and Their Effects on the Metabolic Profile of Breast Milk: A Systematic Review.

Cureus·2026
Same author

The current understanding of KRAS oligomerization on membranes.

Current opinion in structural biology·2025
Same author

Preparation of Alginate/AgNP Nanocomposite Hydrogels Incorporating Olive Leaf Extracts in Natural Deep Eutectic Solvents.

Polymers·2025

Related Experiment Video

Updated: Jan 18, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.6K

G.AI.A: An Integrated Machine-Learning Platform for Predicting Bioaccumulation and Ecotoxicity of Pharmaceuticals.

Evangelos Tsoukas1, Michail Papadourakis1, Eleni Chontzopoulou1

  • 1Cloudpharm PC, Athens 15125, Greece.

Journal of Chemical Information and Modeling
|January 16, 2026
PubMed
Summary
This summary is machine-generated.

This study introduces a computational framework and web platform (G.AI.A) to predict pharmaceutical environmental risks in fish, including bioconcentration and ecotoxicity. The tool aids sustainable drug design by assessing compounds and their metabolites for ecological safety.

More Related Videos

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
09:01

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans

Published on: March 14, 2019

7.6K
Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

3.2K

Related Experiment Videos

Last Updated: Jan 18, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.6K
A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
09:01

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans

Published on: March 14, 2019

7.6K
Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

3.2K

Area of Science:

  • Environmental Chemistry
  • Computational Toxicology
  • Green Chemistry

Background:

  • Pharmaceuticals in aquatic environments pose ecological risks due to bioactive compound accumulation.
  • Existing risk assessment methods can be time-consuming and resource-intensive.
  • There is a need for predictive tools to support sustainable chemical management and drug design.

Purpose of the Study:

  • To develop a computational framework for predicting fish bioconcentration and ecotoxicity.
  • To integrate metabolite prediction for comprehensive environmental risk assessment.
  • To create an accessible web platform (G.AI.A) for rapid environmental risk evaluation.

Main Methods:

  • Development of machine learning models for bioconcentration (BCF) and ecotoxicity (LC50) prediction.
  • Incorporation of metabolite prediction using the SyGMa tool.
  • Utilized molecular fingerprint analysis for model interpretability.
  • Benchmarking of multiple tools for metabolite prediction.

Main Results:

  • High-performing ML models achieved ROC AUC scores of 94.60% for bioconcentration and 96.06% for ecotoxicity.
  • The framework successfully predicts risks for both parent compounds and their metabolites.
  • The G.AI.A web platform provides rapid predictions via SMILES input and supports batch processing.

Conclusions:

  • The developed framework and G.AI.A platform advance predictive toxicology for pharmaceuticals.
  • This approach supports green-by-design pharmaceutical development and sustainable chemical management.
  • The tool enables early-stage environmental risk assessment for regulatory bodies and researchers.